Jyothi Datta is a journalist at businessline. She covers a diverse range of topics, focusing on medicine and healthcare, pharmaceuticals, and business economics, with a particular interest in public health, consumer health, and patient care. Jyothi's insights and expertise have been featured in various publications, including businessline.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
India (National)
Not enough data
Jyothi Datta's coverage primarily focuses on healthcare and pharmaceuticals, with a strong emphasis on COVID-19, medical research, vaccines, public health, and healthcare. She frequently covers government announcements and press releases in her articles.
Given the nature of Jyothi's coverage, she would likely be interested in pitches that offer expert insights into the latest developments in healthcare policies or breakthroughs in medical research. Furthermore, sources who can provide data-driven analysis related to public health trends or vaccine efficacy may find success when reaching out to Jyothi.
Although no specific geographic focus is indicated for Jyothi's coverage attributes suggests that she takes an international view of healthcare topics. Therefore, experts from around the world could potentially engage effectively with her through relevant and insightful pitches.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jyothi Datta
The Aiocd had called for a day-long strike about a week ago, against what it called ‘predatory pricing'
Passengers travelling from, or through high-risk regions including DRC, Uganda and South Sudan with symptoms are required to contact the airport health officer before immigration clearance, a health ministry advisory stated
By: Jyothi Datta
Plans to file with the Indian regulator too, seeking approvals for the higher dose
By: Jyothi Datta
Symptoms include fever, headache and unexpected bleeding, among others; and it transmits through human contact with a body or bodily fluids of people suspected of having Ebola
By: Jyothi Datta
International health administrators are worried at the speed of the spread, exacerbated by, among other things, weak health infrastructure, reduced US funding and conflict in some regions.
Public health technologies from the Indian Council of Medical Research (ICMR), covering vaccines, diagnostics and biomedical solutions, have been transferred to industry partners for commercialisation.
In India, AccelRare is approved as a web-based pre-diagnostic tool for suspected rare diseases
By: Jyothi Datta
MedTherapy was founded in the US in 2018 and incorporated in India in 2020, he said, and pointed to support from the late Ratan Tata in helping bring breakthrough therapies (especially for cancer) to India
This year's cohort includes pioneers and leaders across a range of scientific fields, from astronomy and cancer research to mathematics and biotechnology, says the Society
By: Jyothi Datta
Patni family venture to price medicines 15-20 per cent lower and target ₹1,000 crore revenue in five years
